EVAX logo

Evaxion Biotech A/S (EVAX) Company Overview

Profile

Full Name:

Evaxion Biotech A/S

Sector:

Healthcare

Industry:

Biotechnology

Country:

Denmark

IPO:

February 5, 2021

Indexes:

Not included

Description:

Evaxion Biotech A/S is a biotechnology company focused on developing innovative immunotherapies and vaccines. Using advanced artificial intelligence, they create personalized treatments for cancer and infectious diseases, aiming to improve patient outcomes and enhance the effectiveness of existing therapies.

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Oct 31, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 14, 2025

Analyst ratings

Recent major analysts updates

Feb 20, 25 HC Wainwright & Co.
Buy
Feb 4, 25 Lake Street
Buy
Feb 3, 25 HC Wainwright & Co.
Buy
Nov 1, 24 HC Wainwright & Co.
Buy
Sep 26, 24 HC Wainwright & Co.
Buy
Sep 20, 24 HC Wainwright & Co.
Buy
Aug 16, 24 HC Wainwright & Co.
Buy
Aug 1, 24 HC Wainwright & Co.
Buy
Jun 4, 24 HC Wainwright & Co.
Buy
Apr 3, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Evaxion Biotech A/S?
  • Does Evaxion Biotech A/S pay dividends?
  • What sector is Evaxion Biotech A/S in?
  • What industry is Evaxion Biotech A/S in?
  • What country is Evaxion Biotech A/S based in?
  • When did Evaxion Biotech A/S go public?
  • Is Evaxion Biotech A/S in the S&P 500?
  • Is Evaxion Biotech A/S in the NASDAQ 100?
  • Is Evaxion Biotech A/S in the Dow Jones?
  • When was Evaxion Biotech A/S's last earnings report?
  • When does Evaxion Biotech A/S report earnings?
  • Should I buy Evaxion Biotech A/S stock now?

What is the ticker symbol for Evaxion Biotech A/S?

The ticker symbol for Evaxion Biotech A/S is NASDAQ:EVAX

Does Evaxion Biotech A/S pay dividends?

No, Evaxion Biotech A/S does not pay dividends

What sector is Evaxion Biotech A/S in?

Evaxion Biotech A/S is in the Healthcare sector

What industry is Evaxion Biotech A/S in?

Evaxion Biotech A/S is in the Biotechnology industry

What country is Evaxion Biotech A/S based in?

Evaxion Biotech A/S is headquartered in Denmark

When did Evaxion Biotech A/S go public?

Evaxion Biotech A/S's initial public offering (IPO) was on February 5, 2021

Is Evaxion Biotech A/S in the S&P 500?

No, Evaxion Biotech A/S is not included in the S&P 500 index

Is Evaxion Biotech A/S in the NASDAQ 100?

No, Evaxion Biotech A/S is not included in the NASDAQ 100 index

Is Evaxion Biotech A/S in the Dow Jones?

No, Evaxion Biotech A/S is not included in the Dow Jones index

When was Evaxion Biotech A/S's last earnings report?

Evaxion Biotech A/S's most recent earnings report was on Oct 31, 2024

When does Evaxion Biotech A/S report earnings?

The next expected earnings date for Evaxion Biotech A/S is Mar 27, 2025

Should I buy Evaxion Biotech A/S stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions